Table 1 Clinicopathological characteristics of the patients
Variable | Hepatic resection (n = 44)* | Non-hepatic resection (n = 37)* | p value |
|---|---|---|---|
Age | 64.9 ± 10.0 | 70.6 ± 9.8 | 0.012 |
Sex (M:F) | 23:21 | 19:18 | > 0.999 |
BMI (kg/m2) | 22.5 ± 2.9 | 23.1 ± 3.1 | 0.407 |
ASA (1/2/3/4) | 3/30/11/0 | 1/19/16/1 | 0.157 |
Combined GB stone | 7 (15.9%) | 9 (24.3%) | 0.407 |
CEA (ng/mL) | 4.1 ± 6.1 | 4.6 ± 8.1 | 0.780 |
CA19-9 (U/mL) | 58.9 ± 105.5 | 38.2 ± 90.1 | 0.431 |
Operation time (min) | 342.5 ± 100.5 | 153.7 ± 102.3 | < 0.001 |
Complication rate | 10 (22.7%) | 6 (16.2%) | 0.579 |
Clavien-Dindo classification (I, II, IIIa/IIIb, IV, V) | 10/0 (22.7%/0%) | 5/1 (13.5%/2.7%) | 0. 323 |
Tumor size (mm) | 30.7 ± 17.4 | 26.0 ± 16.2 | 0.213 |
 T2a | 20 (45.5%) | 16 (43.2%) | > 0.999 |
 T2b | 24 (54.5%) | 21 (56.8%) |  |
 N0 | 28 (63.6%) | 15 (40.5%) | < 0.001 |
 N1 | 14 (31.8%) | 6 (16.2%) |  |
 N2 | 2 (4.5%) | 0 (0%) |  |
 Nx | 0 (0%) | 16 (43.2%) |  |
Adjuvant chemotherapy | 23 (52.3%) | 10 (27.0%) | 0.025 |
Hospital stay (day) | 13.3 ± 5.7 | 8.8 ± 8.8 | 0.009 |